Chemed Return on Tangible Equity 2010-2025 | CHE

Current and historical return on tangible equity values for Chemed (CHE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Chemed Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.31B $0.43B 72.41%
2024-12-31 $0.30B $0.36B 67.64%
2024-09-30 $0.30B $0.47B 64.98%
2024-06-30 $0.30B $0.45B 69.76%
2024-03-31 $0.28B $0.50B 72.84%
2023-12-31 $0.27B $0.43B 86.97%
2023-09-30 $0.24B $0.34B 104.27%
2023-06-30 $0.23B $0.28B 142.59%
2023-03-31 $0.24B $0.20B 266.30%
2022-12-31 $0.25B $0.12B 716.55%
2022-09-30 $0.26B $0.04B -2495.24%
2022-06-30 $0.28B $0.00B 11080.00%
2022-03-31 $0.27B $-0.02B 570.21%
2021-12-31 $0.27B $-0.06B 243.44%
2021-09-30 $0.31B $0.09B 173.52%
2021-06-30 $0.30B $0.18B 168.65%
2021-03-31 $0.33B $0.24B 222.67%
2020-12-31 $0.32B $0.21B 378.70%
2020-09-30 $0.27B $0.10B 697.44%
2020-06-30 $0.26B $0.05B 5009.52%
2020-03-31 $0.23B $-0.02B 7733.33%
2019-12-31 $0.22B $0.02B 2210.00%
2019-09-30 $0.21B $-0.03B 2786.67%
2019-06-30 $0.20B $0.04B 883.52%
2019-03-31 $0.21B $0.01B 1108.11%
2018-12-31 $0.21B $0.01B 2157.89%
2018-09-30 $0.21B $0.03B 2423.53%
2018-06-30 $0.19B $0.02B -1727.27%
2018-03-31 $0.11B $-0.03B -318.31%
2017-12-31 $0.10B $0.01B -274.13%
2017-09-30 $0.08B $-0.05B -193.55%
2017-06-30 $0.07B $-0.08B -184.83%
2017-03-31 $0.11B $-0.03B -335.29%
2016-12-31 $0.11B $0.00B -286.84%
2016-09-30 $0.11B $-0.04B -262.58%
2016-06-30 $0.11B $-0.07B -267.48%
2016-03-31 $0.11B $-0.04B -300.00%
2015-12-31 $0.11B $-0.01B -294.04%
2015-09-30 $0.11B $-0.04B -213.46%
2015-06-30 $0.11B $-0.05B -165.25%
2015-03-31 $0.10B $-0.05B -144.95%
2014-12-31 $0.10B $-0.07B -125.79%
2014-09-30 $0.09B $-0.09B -115.53%
2014-06-30 $0.09B $-0.08B -103.66%
2014-03-31 $0.08B $-0.08B -104.47%
2013-12-31 $0.08B $-0.08B -121.74%
2013-09-30 $0.08B $-0.10B -130.65%
2013-06-30 $0.09B $-0.04B -170.00%
2013-03-31 $0.09B $-0.04B -158.26%
2012-12-31 $0.09B $-0.07B -128.99%
2012-09-30 $0.09B $-0.05B -113.18%
2012-06-30 $0.09B $-0.07B -101.14%
2012-03-31 $0.09B $-0.09B -114.29%
2011-12-31 $0.09B $-0.11B -125.55%
2011-09-30 $0.08B $-0.09B -148.88%
2011-06-30 $0.08B $-0.03B -309.43%
2011-03-31 $0.08B $-0.05B -450.00%
2010-12-31 $0.08B $-0.05B -1093.33%
2010-09-30 $0.08B $0.03B -4400.00%
2010-06-30 $0.08B $0.01B -348.84%
2010-03-31 $0.07B $-0.01B -176.97%
2009-12-31 $0.07B $-0.03B -116.80%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.922B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.751B 19.46
Encompass Health (EHC) United States $11.999B 25.44
DaVita (DVA) United States $10.763B 15.13
Elanco Animal Health (ELAN) United States $7.271B 15.57
Option Care Health (OPCH) United States $5.102B 22.75
RadNet (RDNT) United States $4.217B 267.62
Amedisys (AMED) United States $3.154B 21.21
Addus HomeCare (ADUS) United States $2.058B 22.60
LifeStance Health (LFST) United States $1.863B 0.00
Astrana Health (ASTH) United States $1.417B 35.11
U.S Physical Therapy (USPH) United States $1.248B 32.21
Aveanna Healthcare Holdings (AVAH) United States $0.907B 51.67
Pennant (PNTG) United States $0.907B 33.29
Atai Life Sciences (ATAI) Germany $0.555B 0.00
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.040B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00